Central Retinal Artery Occlusion

Differentiating between central retinal artery occlusion (CRAO) and branch retinal artery occlusion (BRAO) relies on observing the affected area of the retina. In CRAO, the entire retina appears pale and edematous, with a cherry-red spot in the fovea due to preserved choroidal circulation. Vision loss is profound and often described as sudden, painless, and unilateral. In BRAO, the retinal whitening and edema are confined to the distribution of the affected arteriole, resulting in a more localized visual field defect. While CRAO typically presents with a complete afferent pupillary defect, BRAO often presents with a relative afferent pupillary defect depending on the severity. Fundus photography and fluorescein angiography can confirm the diagnosis and delineate the affected retinal area, aiding in the differentiation. Explore how incorporating optical coherence tomography angiography (OCTA) can enhance the visualization of retinal perfusion in CRAO and BRAO.

Time is of the essence in managing acute central retinal artery occlusion (CRAO). Immediate management focuses on restoring retinal blood flow. Interventions include ocular massage to dislodge emboli, anterior chamber paracentesis to lower intraocular pressure, and administration of carbogen (95% oxygen and 5% carbon dioxide) to induce vasodilation. Intravenous thrombolytics may be considered in selected cases within a narrow time window. Systemic evaluation to identify the underlying cause of CRAO, such as carotid artery disease, cardiac embolism, or vasculitis, is crucial. Consider implementing a standardized CRAO protocol that includes rapid assessment, initiation of ocular interventions, and prompt referral to a specialist for further management and long-term care. Learn more about emerging therapies like intra-arterial thrombolysis and neuroprotection strategies being explored for CRAO.

The presence of a patent cilioretinal artery in central retinal artery occlusion (CRAO) significantly influences the prognosis for visual recovery. If the cilioretinal artery, which supplies the macula in some individuals, is spared, central vision may be preserved, allowing for better functional outcomes. However, even with cilioretinal artery sparing, the overall visual field will still be affected. Conversely, without cilioretinal artery sparing, severe and permanent central vision loss is more likely. When counseling patients with CRAO, it's important to explain the role of the cilioretinal artery and how its patency can affect the visual prognosis. Provide clear and realistic expectations based on the individual's presentation, emphasizing the importance of long-term follow-up to monitor for complications like neovascular glaucoma. Consider implementing educational resources to help patients understand and adapt to their vision changes.